ORLANDO, FL USA (UroToday.com) - During the “Advanced Prostate Cancer II” session, Dr. Matthew Cooperberg presented data from PROCEED, an ongoing Phase 4 registry of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with sipuleucel-T (ST).

ORLANDO, FL USA (UroToday.com) - Dr. David Penson presented a state-of-the-art lecture on evidence-based versus consensus-based guidelines on PSA testing.

ORLANDO, FL USA (UroToday.com) - Dr. Steven Larson presented work from his group at MSKCC on positron emission tomography (PET) which he is using to identify locally invasive and castration-resistant prostate cancer (CRPC), based on biological rationales.

ORLANDO, FL USA (UroToday.com) - Dr. Dan Theodorescu from the University of Colorado gave a “call to arms” for urologists to be aware of and develop biomarkers for bladder cancer.

ORLANDO, FL USA (UroToday.com) - Dr. Michael Liss, a urologic oncology fellow at University of California-Irvine, presented his work evaluating the benefit of screening men with family history (FH) of prostate cancer.

ORLANDO, FL USA (UroToday.com) - Dr Bhalaajee Meenaski-Sundaram reviewed SEER-Medicare data to compare outcomes of patients diagnosed with prostate cancer prior to kidney transplant (KT) to the general prostate cancer population, hypothesizing that the outcomes were equivalent.

ORLANDO, FL USA (UroToday.com) - Hematuria is associated with renal cell carcinoma (RCC). However, its relationship with specific pathologic subtypes has not been evaluated. Michael Hanzly and colleagues sought to evaluate whether hematuria could be predictive for subtype of RCC and benign renal masses.

ORLANDO, FL USA (UroToday.com) - Although level I evidence supporting active surveillance (AS) of solid malignancies is absent, institutional studies and pooled analyses provide robust contemporary data that an initial short-term period of observation to determine tumor growth kinetics may be safe for small enhancing tumors, in select candidates.

ORLANDO, FL USA (UroToday.com) - Increased use of abdominal imaging over the last three decades has led to a rise in the incidental detection of asymptomatic small renal masses (SRMs), typically defined as tumors 4 cm or less in diameter, and the greatest number of cases are now found in patients over 70 years of age.

ORLANDO, FL USA (UroToday.com) - Active surveillance (AS) for small renal masses has emerged as a viable clinical strategy in patients with significant competing risks of death.